Challenges in liver cancer and possible treatment approaches
… vaccines to prevent infection or inflammatory responses, and by non-specific cancer
immunotherapies that provide a general boost to the immune system. In 2013, this field of research …
immunotherapies that provide a general boost to the immune system. In 2013, this field of research …
[PDF][PDF] Correlation between inflammatory cytokines and liver cancer stem cell markers in DEN-induced liver cancer rats
ZH Liu, MJ Bai, JQ Li, SH Yan, XW Ye… - Eur. Rev. Med …, 2021 - europeanreview.org
… liver cancer stem cell markers, thereby promoting the occurrence and progression of liver
cancer… MicroRNA expression, survival and response to interferon in liver cancer. N Engl J Med …
cancer… MicroRNA expression, survival and response to interferon in liver cancer. N Engl J Med …
Early prediction of response focused on tumor markers in atezolizumab plus bevacizumab therapy for hepatocellular carcinoma
N Tanabe, I Saeki, Y Aibe, T Matsuda, T Hanazono… - Cancers, 2023 - mdpi.com
… treatment response. Tumor markers are useful in predicting treatment response and prognosis.
… The staging was based on the Barcelona Clinic Liver Cancer (BCLC) staging system [4]. …
… The staging was based on the Barcelona Clinic Liver Cancer (BCLC) staging system [4]. …
Biomarkers and genetic markers of hepatocellular carcinoma and cholangiocarcinoma—what do we already know
J Baj, Ł Bryliński, F Woliński, M Granat, K Kostelecka… - Cancers, 2022 - mdpi.com
… liver cancer with an increasing worldwide mortality rate. Cholangiocarcinoma (CCA) is the
second most common primary liver cancer… to a lack or to a poor response to the treatment [48]. …
second most common primary liver cancer… to a lack or to a poor response to the treatment [48]. …
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
K Yamamoto, H Imamura, Y Matsuyama… - Journal of …, 2010 - Springer
… Marker values of these 77 patients 1 month post-surgery … of tumor markers to reflect the
therapeutic response after curative … proposed by the Liver Cancer Study Group of Japan [16]. …
therapeutic response after curative … proposed by the Liver Cancer Study Group of Japan [16]. …
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling
… This is especially important in cancers of the liver and pancreas, which … markers such as
α fetoprotein (AFP), glypican 3 (Gpc3), and Ly6D, whose expression in mouse liver cancer …
α fetoprotein (AFP), glypican 3 (Gpc3), and Ly6D, whose expression in mouse liver cancer …
Serum markers of hepatocellular carcinoma
G Malaguarnera, M Giordano, I Paladina… - Digestive diseases and …, 2010 - Springer
… of liver function and tumor characteristics to establish a prognosis for HCC patients, and patients
are followed-up to monitor the response to … , indicates a favorable response to treatment. …
are followed-up to monitor the response to … , indicates a favorable response to treatment. …
CD13 is a therapeutic target in human liver cancer stem cells
N Haraguchi, H Ishii, K Mimori… - The Journal of …, 2010 - Am Soc Clin Investig
… Here, we have demonstrated that CD13 is a marker for semiquiescent CSCs in human liver
cancer cell lines and clinical samples and that targeting these cells might provide a way to …
cancer cell lines and clinical samples and that targeting these cells might provide a way to …
Early tumor marker response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving combined lenvatinib, immune checkpoint …
MC Luo, JY Wu, JY Wu, ZT Lin, YN Li… - Journal of …, 2023 - Taylor & Francis
… Therefore, this study explored the clinical utility of early AFP and DCP responses as …
The primary endpoint of this study was ORR, assessed according to the modified Response …
The primary endpoint of this study was ORR, assessed according to the modified Response …
… of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma …
… response after treatment. This study was aimed to assess the clinical outcome of HCC
patients who had achieved a complete response but later presented with elevated tumor marker …
patients who had achieved a complete response but later presented with elevated tumor marker …